Adam D Toll

Summary

Affiliation: Thomas Jefferson University Hospital
Country: USA

Publications

  1. doi Acinar cell carcinoma with prominent intraductal growth pattern: case report and review of the literature
    Adam D Toll
    Department of Pathology, Anatomy and Cell Biology, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania 19107, USA
    Int J Surg Pathol 19:795-9. 2011
  2. ncbi Expression of K homology domain containing protein (KOC) in pancreatic cytology with corresponding histology
    Adam D Toll
    Department of Pathology, Anatomy and Cell Biology, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania 19107, USA
    Acta Cytol 53:123-9. 2009
  3. ncbi Identification of gastrointestinal contamination in endoscopic ultrasound-guided pancreatic fine needle aspiration
    Adam D Toll
    Department of Pathology, Anatomy and Cell Biology, Thomas Jefferson University Hospital, 132 South 10th Street, 285 Main Building, Philadelphia, Pennsylvania 19107, USA
    Acta Cytol 54:245-8. 2010
  4. ncbi The added value of molecular testing in small pancreatic cysts
    Adam D Toll
    Department of Pathology, Anatomy, and Cell Biology, Thomas Jefferson University Hospital, Philadelphia, PA 19107, USA
    JOP 11:582-6. 2010
  5. doi Does routine repeat testing of critical values offer any advantage over single testing?
    Adam D Toll
    Department of Pathology, Anatomy, and Cell Biology, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania 19107, USA
    Arch Pathol Lab Med 135:440-4. 2011
  6. doi Implications of enhancer of zeste homologue 2 expression in pancreatic ductal adenocarcinoma
    Adam D Toll
    Department of Pathology, Thomas Jefferson University, Jefferson Pancreas, Biliary and Related Cancer Center, Philadelphia, PA 19107, USA
    Hum Pathol 41:1205-9. 2010
  7. doi Urinary cytopathology in primary bladder amyloidosis
    Adam D Toll
    Department of Pathology, The Johns Hopkins Hospital, Baltimore, MD 21287, USA
    Acta Cytol 57:271-5. 2013
  8. pmc Acinar cell carcinoma of the pancreas: clinical and cytomorphologic characteristics
    Adam D Toll
    Department of Pathology, The Johns Hopkins Hospital, Baltimore, MD, USA
    Korean J Pathol 47:93-9. 2013
  9. doi Dysplastic lesions in inflammatory bowel disease show increased positivity for the stem cell marker aldehyde dehydrogenase
    Adam D Toll
    Department of Pathology, Anatomy and Cell Biology, Thomas Jefferson University Hospital, Philadelphia, PA 19107, USA
    Hum Pathol 43:238-42. 2012
  10. doi Urinary cytomorphology and clinical correlates of prostatic small cell neuroendocrine carcinoma
    Adam D Toll
    Department of Pathology, The Johns Hopkins Hospital, Baltimore, MD, USA
    Acta Cytol 57:495-500. 2013

Detail Information

Publications12

  1. doi Acinar cell carcinoma with prominent intraductal growth pattern: case report and review of the literature
    Adam D Toll
    Department of Pathology, Anatomy and Cell Biology, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania 19107, USA
    Int J Surg Pathol 19:795-9. 2011
    ..In addition, the authors review the published cases reporting acinar cell carcinoma with intraductal and/or papillary growth patterns...
  2. ncbi Expression of K homology domain containing protein (KOC) in pancreatic cytology with corresponding histology
    Adam D Toll
    Department of Pathology, Anatomy and Cell Biology, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania 19107, USA
    Acta Cytol 53:123-9. 2009
    ....
  3. ncbi Identification of gastrointestinal contamination in endoscopic ultrasound-guided pancreatic fine needle aspiration
    Adam D Toll
    Department of Pathology, Anatomy and Cell Biology, Thomas Jefferson University Hospital, 132 South 10th Street, 285 Main Building, Philadelphia, Pennsylvania 19107, USA
    Acta Cytol 54:245-8. 2010
    ..To evaluate whether B72.3 and CEA could identify duodenal and gastric contamination in cell blocks of clinically proven cases of pancreatic ductal carcinoma, intraductal papillary mucinous neoplasm (IPMN) and mucinous cystic neoplasm (MCN)...
  4. ncbi The added value of molecular testing in small pancreatic cysts
    Adam D Toll
    Department of Pathology, Anatomy, and Cell Biology, Thomas Jefferson University Hospital, Philadelphia, PA 19107, USA
    JOP 11:582-6. 2010
    ..Recent studies have shown high amplitude K-ras gene mutation and allelic imbalances are predictive of malignancy in pancreatic cysts...
  5. doi Does routine repeat testing of critical values offer any advantage over single testing?
    Adam D Toll
    Department of Pathology, Anatomy, and Cell Biology, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania 19107, USA
    Arch Pathol Lab Med 135:440-4. 2011
    ..Before being communicated to the caregiver, critical laboratory values are verified by repeat testing to ensure their accuracy and to avoid reporting false or erroneous results...
  6. doi Implications of enhancer of zeste homologue 2 expression in pancreatic ductal adenocarcinoma
    Adam D Toll
    Department of Pathology, Thomas Jefferson University, Jefferson Pancreas, Biliary and Related Cancer Center, Philadelphia, PA 19107, USA
    Hum Pathol 41:1205-9. 2010
    ..Our study suggests that E-cadherin down-regulation may lead to enhancer of zeste homologue 2-mediated invasion and metastasis...
  7. doi Urinary cytopathology in primary bladder amyloidosis
    Adam D Toll
    Department of Pathology, The Johns Hopkins Hospital, Baltimore, MD 21287, USA
    Acta Cytol 57:271-5. 2013
    ..Isolated collections of amyloid within the bladder are extremely uncommon, and a cytopathologic description in voided urine has not been described to date...
  8. pmc Acinar cell carcinoma of the pancreas: clinical and cytomorphologic characteristics
    Adam D Toll
    Department of Pathology, The Johns Hopkins Hospital, Baltimore, MD, USA
    Korean J Pathol 47:93-9. 2013
    ..Approximately 50% of patients have metastatic disease at presentation, often restricted to the regional lymph nodes and liver. The prognosis is poor, only slightly better than that of pancreatic ductal adenocarcinoma...
  9. doi Dysplastic lesions in inflammatory bowel disease show increased positivity for the stem cell marker aldehyde dehydrogenase
    Adam D Toll
    Department of Pathology, Anatomy and Cell Biology, Thomas Jefferson University Hospital, Philadelphia, PA 19107, USA
    Hum Pathol 43:238-42. 2012
    ..Our findings support the hypothesis that dysplasia in inflammatory bowel disease is associated with increased aldehyde dehydrogenase positivity, which supports the cancer stem cell hypothesis...
  10. doi Urinary cytomorphology and clinical correlates of prostatic small cell neuroendocrine carcinoma
    Adam D Toll
    Department of Pathology, The Johns Hopkins Hospital, Baltimore, MD, USA
    Acta Cytol 57:495-500. 2013
    ..Future work should hopefully clarify the role of ERG gene rearrangements in the pathogenesis of prostatic SCC, as there is a potential role here for targeted therapy. © 2013 S. Karger AG, Basel. ..
  11. doi Acral myxoinflammatory fibroblastic sarcoma: cytopathologic findings on fine-needle aspiration
    Adam D Toll
    Department of Pathology, The Johns Hopkins Hospital, Baltimore, MD, USA
    Acta Cytol 57:134-8. 2013
    ..While recurrences are relatively common, distant metastases are infrequent. Cytopathologic descriptions of AMFS are limited, prompting the current study...
  12. pmc Low prostate-specific antigen and no Gleason score upgrade despite more extensive cancer during active surveillance predicts insignificant prostate cancer at radical prostatectomy
    Jeong S Han
    Department of Pathology, The Johns Hopkins Medical Institutions, Baltimore, MD, USA
    Urology 80:883-8. 2012
    ..To identify parameters that predict insignificant prostate cancer in 67 radical prostatectomies after biopsy reclassification to worse disease on active surveillance...